Gilead Sciences, Inc. (GILD) Presents at Morgan Stanley 23rd Annual Global Healthcare

Core Insights - The company has been on a diversification journey for several years, indicating a strategic shift in its business model [3] Company Update - The company is focusing on providing an update on the progress made in its diversification efforts [3] - The leadership is looking ahead to the next 12 to 18 months to identify key focus points for future growth [3]